Home・Elenco Azioni・Codexis Inc

Codexis Inc

Chiusa

SettoreSettore sanitario

1.39 -6.08

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.37

Massimo

1.3900000000000001

Metriche Chiave
By Trading Economics
Entrata	-18M -8.7M
Vendite	-24M 15M
EPS	-0.1
Margine di Profitto	-57.083
Dipendenti	146
EBITDA	-23M -6.4M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+423.57% upside

Dividendi
By Acuity
Utili prossimi	11 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-87M 141M
Apertura precedente	7.47
Chiusura precedente	1.39

Notizie sul Sentiment di mercato

By Acuity

91%

6 / 340 Classifica in Healthcare

Codexis Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

31 lug 2026, 20:02 UTC

Codexis Inc shares are trading lower today, continuing a broader decline. The stock is near the lower end of its one-month range.

30 lug 2026, 20:09 UTC

Codexis Inc shares are higher today, continuing their rise since Wednesday's close. Broader market volatility is influenced by mixed economic signals.

29 lug 2026, 19:47 UTC

Macro Event

Codexis Inc shares are lower amid broader market declines and heightened volatility following the Federal Reserve's decision to keep interest rates steady.

28 lug 2026, 19:51 UTC

Codexis Inc. shares are trading lower today, reflecting a downward trend since Monday, with a notable decline from an earlier session high.

27 lug 2026, 19:21 UTC

News

Codexis Inc shares are higher today, supported by early customer orders and interest from CDMOs. The stock remains up since Friday's close.

24 lug 2026, 19:01 UTC

News

Codexis Inc shares are lower following a public offering of 16.67 million shares at $1.50 each, below Thursday's close of $1.99.

23 lug 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

22 lug 2026, 20:01 UTC

Codexis Inc shares are lower during Wednesday's session, continuing a trend of declines since Tuesday's close. The stock remains below its 20-day moving average.

Confronto tra pari

Modifica del prezzo

Codexis Inc Previsione

Obiettivo di Prezzo

By TipRanks

423.57% in crescita

Previsioni per 12 mesi

Media 7.33 USD 423.57%

Alto 11 USD

Basso 2 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Codexis Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Codexis Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

6 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.